News
Baiwang Co. , Ltd. Signs Industry-Academia-Research Cooperation Agreement with Zhongguancun Academy and Institute of Artificial Intelligence to Advance Data Intelligence and AI Applications 1
1+ hour, 33+ min ago (328+ words) Minichart Baiwang Co. , Ltd. Signs Industry-Academia-Research Cooperation Agreement with Zhongguancun Academy and Institute of Artificial Intelligence to Advance Data Intelligence and AI Applications 1 Baiwang Co. , Ltd. Announces Strategic AI Partnership with Zhongguancun Institutions - Baiwang Co. , Ltd. has entered into a…...
a Tyr Pharma Reports Q1 2026 Results, Advances Efzofitimod Phase 3 for Pulmonary Sarcoidosis After FDA Meeting
12+ hour, 16+ min ago (17+ words) Minichart...
Cabaletta Bio Unveils Promising Preconditioning-Free Rese-cel CAR-T Data and Automated Manufacturing Advances at ASGCT 2026 Annual Meeting
1+ day, 10+ hour ago (435+ words) Minichart Cabaletta Bio Unveils Promising Preconditioning-Free Rese-cel CAR-T Data and Automated Manufacturing Advances at ASGCT 2026 Annual Meeting Cabaletta Bio Showcases Promising Preconditioning-Free Rese-cel Data and Manufacturing Breakthroughs at ASGCT 2026 Key Highlights for Investors - Compelling Early Clinical Results: In a Phase…...
Sino Mab Presents Promising Preclinical Results of First-in-Class Anti-CGC Antibody (h C2) for Alopecia Areata and Vitiligo at SID 2026 Annual Meeting 1 " Minichart
1+ day, 14+ hour ago (126+ words) The study, led by Chin Wai HUI of Sino Mab, investigated h C2s effects in two humanized disease models using transplanted human autoreactive T cells: Treatment with h C2 was associated with: The effects were shown to be dose-dependent, further supporting the…...
Sino Biopharmaceutical Presents Preclinical Data on TQF6422 Act RII A/B Monoclonal Antibody for High-Quality Weight Loss at ECO 2026 12
2+ day, 2+ hour ago (370+ words) Minichart Sino Biopharmaceutical Presents Preclinical Data on TQF6422 Act RII A/B Monoclonal Antibody for High-Quality Weight Loss at ECO 2026 12 Sino Biopharmaceutical Limited: Major Breakthrough in Weight Loss Drug Development with TQF6422 Sino Biopharmaceutical Limited (Stock Code: 1177) has released a voluntary announcement…...
Shanghai Henlius Biotech Receives Approval for Phase 1 Clinical Trial of HLX48 Bispecific ADC Targeting EGFR and c-MET in Australia 1 " Minichart
2+ day, 3+ hour ago (335+ words) Shanghai Henlius Biotech Receives Approval for Phase 1 Clinical Trial of HLX48 Bispecific ADC Targeting EGFR and c-MET in Australia 1 Minichart Shanghai Henlius Biotech Receives Approval for Phase 1 Clinical Trial of HLX48 Bispecific ADC Targeting EGFR and c-MET in Australia 1 Shanghai Henlius Biotech…...
HIVE Digital Technologies Builds Grand Falls as Eastern Canada's First Sovereign AI Factory with $3. 1 M Fibre Optic Investment
3+ day, 12+ hour ago (357+ words) According to HIVE's Executive Chairman, Frank Holmes, the global competition for AI infrastructure has become "the new industrial race." Holmes emphasized that nations building sovereign AI factories will enhance their productivity, security, and data sovereignty, insulating themselves from reliance on…...
Dynamic Aerospace Systems and Arizona DPS Host Multi-Agency Drone Demo Expo Showcasing U. S. -Manufactured UAVs for Public Safety and Government Use 12
2+ week, 3+ hour ago (318+ words) Minichart Dynamic Aerospace Systems and Arizona DPS Host Multi-Agency Drone Demo Expo Showcasing U. S. -Manufactured UAVs for Public Safety and Government Use 12 Dynamic Aerospace Systems (OTCQB: BRQL) Announces Multi-Agency Drone Demo Expo Amid Surging Demand for U. S. -Manufactured UAVs - Dynamic Aerospace Systems…...
Shanghai Zhida Launches Home Automated Charging Robot, Unmanned Public Charging, and Overseas EV Charger Nexus at 2026 Innovation Event
2+ week, 5+ day ago (415+ words) Minichart We value your privacy No cookies to display. Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Advertisement cookies are used to provide visitors with…...
Hanx Biopharmaceuticals Showcases Four Innovative Cancer Therapies at 2026 AACR Meeting, Highlighting Advances in ADCs and Immunotherapy
3+ week, 23+ min ago (398+ words) Minichart Hanx Biopharmaceuticals Showcases Four Innovative Cancer Therapies at 2026 AACR Meeting, Highlighting Advances in ADCs and Immunotherapy Hanx Biopharmaceuticals Achieves Major R&D Milestones with Four Posters at 2026 AACR Annual Meeting Hanx Biopharmaceuticals (Wuhan) Co. , Ltd. (Stock Code: 3378) announced a…...